Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Location
New Mexico
Santa Fe
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial
Apply
177Lu-DOTATATE vs. Everolimus
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step